205 related articles for article (PubMed ID: 31325518)
1. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits.
Van Erum J; Van Dam D; Sheorajpanday R; De Deyn PP
Behav Brain Res; 2019 Nov; 373():112089. PubMed ID: 31325518
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.
Van Dam D; D'Hooge R; Staufenbiel M; Van Ginneken C; Van Meir F; De Deyn PP
Eur J Neurosci; 2003 Jan; 17(2):388-96. PubMed ID: 12542676
[TBL] [Abstract][Full Text] [Related]
3. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.
Colby-Milley J; Cavanagh C; Jego S; Breitner JC; Quirion R; Adamantidis A
PLoS One; 2015; 10(6):e0130177. PubMed ID: 26076358
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.
Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H
Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341
[TBL] [Abstract][Full Text] [Related]
6. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
8. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
9. Traumatic Brain Injury by Weight-Drop Method Causes Transient Amyloid-
Shishido H; Ueno M; Sato K; Matsumura M; Toyota Y; Kirino Y; Tamiya T; Kawai N; Kishimoto Y
Behav Neurol; 2019; 2019():3248519. PubMed ID: 30944661
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
[TBL] [Abstract][Full Text] [Related]
11. Reduction in open field activity in the absence of memory deficits in the App
Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
[TBL] [Abstract][Full Text] [Related]
12. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse.
Jyoti A; Plano A; Riedel G; Platt B
J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein mutation disrupts reproductive experience-enhanced normal cognitive development in a mouse model of Alzheimer's disease.
Cui J; Jothishankar B; He P; Staufenbiel M; Shen Y; Li R
Mol Neurobiol; 2014 Feb; 49(1):103-12. PubMed ID: 23853041
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
15. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.
Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R
Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225
[TBL] [Abstract][Full Text] [Related]
16. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
Kent BA; Strittmatter SM; Nygaard HB
J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134
[TBL] [Abstract][Full Text] [Related]
17. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
[TBL] [Abstract][Full Text] [Related]
18. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
Fertan E; Wong AA; Vienneau NA; Brown RE
Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
[TBL] [Abstract][Full Text] [Related]
19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner.
Gannon OJ; Robison LS; Salinero AE; Abi-Ghanem C; Mansour FM; Kelly RD; Tyagi A; Brawley RR; Ogg JD; Zuloaga KL
J Neuroinflammation; 2022 May; 19(1):110. PubMed ID: 35568928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
